Literature DB >> 16699534

Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence.

S Shalitin1, M Phillip, J Stein, Y Goshen, D Carmi, I Yaniv.   

Abstract

Endocrine dysfunction and parameters of metabolic syndrome were assessed in 91 patients aged 4.3-32.5 years who underwent allogeneic or autologous BMT in childhood. Final short stature, found in five of the 35 patients who attained final height, was associated with the underlying disease (specifically, Fanconi anemia) (P=0.0013), previous cranial irradiation (P=0.0007), type of conditioning irradiation (P<0.05) and allogeneic BMT (P=0.05). Growth hormone deficiency (n=10) was associated with previous cranial irradiation (P<0.005) and conditioning total body irradiation (P<0.001). Twelve patients had primary hypothyroidism, one had hyperthyroidism and one papillary thyroid carcinoma. Hypothyroidism was associated with neck/mediastinal (P<0.005) and conditioning irradiation (P<0.05). Primary gonadal failure was found in 24 of the mature patients (62.5% females). Hypogonadism was associated with the underlying disease (especially hematological malignancies) (P<0.05), pretransplant treatment (P<0.05), irradiation conditioning (P<0.001), older age (P<0.005) and advanced pubertal stage at BMT (P<0.05). Obesity (body mass index >2 s.d.) was found in 4.4% and type II diabetes and impaired glucose tolerance in 3.3% each. Dyslipidemia was found in 27.9% of the 43 patients tested. These findings emphasize the need for long-term follow-up of endocrine and metabolic parameters in young patients after BMT in order to offer proper treatment and improve quality of life.

Entities:  

Mesh:

Year:  2006        PMID: 16699534     DOI: 10.1038/sj.bmt.1705374

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  29 in total

1.  Body composition after bone marrow transplantation in childhood.

Authors:  Kathy Ruble; Matthew Hayat; Kerry J Stewart; Allen Chen
Journal:  Oncol Nurs Forum       Date:  2012-03       Impact factor: 2.172

Review 2.  Childhood to adult transition and long-term follow-up after blood and marrow transplantation.

Authors:  M C Cupit; C Duncan; B N Savani; S K Hashmi
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

3.  Cardiovascular Risk Factors in Survivors of Childhood Hematopoietic Cell Transplantation Treated with Total Body Irradiation: A Longitudinal Analysis.

Authors:  Danielle Novetsky Friedman; Patrick Hilden; Chaya S Moskowitz; Maya Suzuki; Farid Boulad; Nancy A Kernan; Suzanne L Wolden; Kevin C Oeffinger; Charles A Sklar
Journal:  Biol Blood Marrow Transplant       Date:  2016-12-28       Impact factor: 5.742

4.  Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study.

Authors:  Lillian R Meacham; Charles A Sklar; Suwen Li; Qi Liu; Nora Gimpel; Yutaka Yasui; John A Whitton; Marilyn Stovall; Leslie L Robison; Kevin C Oeffinger
Journal:  Arch Intern Med       Date:  2009-08-10

5.  Late toxicity in children undergoing hematopoietic stem cell transplantation with TBI-containing conditioning regimens for hematological malignancies.

Authors:  Umberto Ricardi; Andrea Riccardo Filippi; Eleonora Biasin; Patrizia Ciammella; Angela Botticella; Pierfrancesco Franco; Andrea Corrias; Elena Vassallo; Riccardo Ragona; Franca Fagioli
Journal:  Strahlenther Onkol       Date:  2009-08       Impact factor: 3.621

6.  A comparison between metabolic syndrome post-hematopoietic stem cell transplantation and spontaneously occurring metabolic syndrome.

Authors:  L Airaghi; P Usardi; S Forti; A Orsatti; M Baldini; C Annaloro; G Lambertenghi Deliliers
Journal:  J Endocrinol Invest       Date:  2010-07-01       Impact factor: 4.256

7.  Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies.

Authors:  Kanae Hirabayashi; Yozo Nakazawa; Hiroki Matsuura; Yosuke Hara; Takashi Kurata; Koichi Hirabayashi; Shoji Saito; Kentaro Yoshikawa; Miyuki Tanaka; Ryu Yanagisawa; Kazuo Sakashita; Kenichi Koike
Journal:  Int J Hematol       Date:  2014-02-21       Impact factor: 2.490

8.  Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study.

Authors:  Can-Lan Sun; John H Kersey; Liton Francisco; Saro H Armenian; K Scott Baker; Daniel J Weisdorf; Stephen J Forman; Smita Bhatia
Journal:  Biol Blood Marrow Transplant       Date:  2013-04-10       Impact factor: 5.742

9.  Hypertension in long-term survivors of pediatric hematopoietic cell transplantation.

Authors:  Paul A Hoffmeister; Sangeeta R Hingorani; Barry E Storer; K Scott Baker; Jean E Sanders
Journal:  Biol Blood Marrow Transplant       Date:  2009-12-02       Impact factor: 5.742

10.  Endocrine complications after hematopoietic stem cell transplantation during childhood and adolescence.

Authors:  Min Ho Jung; Kyoung Soon Cho; Jae Wook Lee; Nak Gyun Chung; Bin Cho; Byung Kyu Suh; Hack Ki Kim; Byung Churl Lee
Journal:  J Korean Med Sci       Date:  2009-11-09       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.